PCVX – vaxcyte, inc. (US:NASDAQ)

News

Vaxcyte (NASDAQ:PCVX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Vaxcyte (NASDAQ:PCVX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
Vaxcyte's Chief Technical Ops Officer Sells Shares [Yahoo! Finance]
What Makes Vaxcyte (PCVX) So Attractive [Yahoo! Finance]
How Vaxcyte's Phase 3 Head-to-Head VAX-31 Trial Could Shape Vaxcyte (PCVX) Investors [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com